These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 37147198)

  • 1. Analysis of Acquisition of COVID-2019 Neutralizing Antibodies in Organ Transplant Recipients.
    Akimoto S; Onoe T; Morimoto H; Yamaguchi S; Shibata Y; Tazuma S; Sada H; Shimada N; Tazawa H; Suzuki T; Sudo T; Shimizu Y; Tashiro H
    Transplant Proc; 2023 May; 55(4):815-819. PubMed ID: 37147198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serological Response and Clinical Protection of Anti-SARS-CoV-2 Vaccination and the Role of Immunosuppressive Drugs in a Cohort of Kidney Transplant Patients.
    Biagio P; Rosa C; Nicola SM; Fabrizio S; Amerigo P; Giulia Z; Riccardo S; Riccardo V; Paolo R; Lorenzo S; Ivan G; Federico Ii Covid Team
    Viruses; 2022 Sep; 14(9):. PubMed ID: 36146758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Past COVID-19 and immunosuppressive regimens affect the long-term response to anti-SARS-CoV-2 vaccination in liver transplant recipients.
    Toniutto P; Falleti E; Cmet S; Cussigh A; Veneto L; Bitetto D; Fornasiere E; Fumolo E; Fabris C; Sartor A; Peressutti R; Curcio F; Regattin L; Grillone L
    J Hepatol; 2022 Jul; 77(1):152-162. PubMed ID: 35283215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A third dose of the BNT162b2 mRNA vaccine sufficiently improves the neutralizing activity against SARS-CoV-2 variants in liver transplant recipients.
    Tomiyama T; Suzuki R; Harada N; Tamura T; Toshida K; Kosai-Fujimoto Y; Tomino T; Yoshiya S; Nagao Y; Takeishi K; Itoh S; Kobayashi N; Ito H; Yoshio S; Kanto T; Yoshizumi T; Fukuhara T
    Front Cell Infect Microbiol; 2023; 13():1197349. PubMed ID: 37260700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutralizing antibody response against the B.1.617.2 (delta) and the B.1.1.529 (omicron) variants after a third mRNA SARS-CoV-2 vaccine dose in kidney transplant recipients.
    Benning L; Morath C; Bartenschlager M; Kim H; Reineke M; Beimler J; Buylaert M; Nusshag C; Kälble F; Reichel P; Töllner M; Schaier M; Klein K; Benes V; Rausch T; Rieger S; Stich M; Tönshoff B; Weidner N; Schnitzler P; Zeier M; Süsal C; Hien Tran T; Bartenschlager R; Speer C
    Am J Transplant; 2022 Jul; 22(7):1873-1883. PubMed ID: 35384272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Anti-COVID-19 Vaccination and Pre-Exposure Prophylaxis with Tixagevimab-Cilgavimab in Kidney and Liver Transplant Recipients.
    Angelico R; Romano F; Coppola L; Materazzo M; Pedini D; Santicchia MS; Cacciola R; Toti L; Sarmati L; Tisone G
    Medicina (Kaunas); 2023 Nov; 59(12):. PubMed ID: 38138204
    [No Abstract]   [Full Text] [Related]  

  • 7. Using machine learning to predict antibody response to SARS-CoV-2 vaccination in solid organ transplant recipients: the multicentre ORCHESTRA cohort.
    Giannella M; Huth M; Righi E; Hasenauer J; Marconi L; Konnova A; Gupta A; Hotterbeekx A; Berkell M; Palacios-Baena ZR; Morelli MC; Tamè M; Busutti M; Potena L; Salvaterra E; ; Feltrin G; Gerosa G; Furian L; Burra P; Piano S; Cillo U; Cananzi M; Loy M; Zaza G; Onorati F; Carraro A; Gastaldon F; Nordio M; Kumar-Singh S; Baño JR; Lazzarotto T; Viale P; Tacconelli E
    Clin Microbiol Infect; 2023 Aug; 29(8):1084.e1-1084.e7. PubMed ID: 37150358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 vaccine antibody response and breakthrough infections in transplant recipients.
    Vanlerberghe B; Vrij C; Bogaerts K; Vermeersch P; Lagrou K; Molenberghs G; Rega F; Ceulemans LJ; van Raemdonck D; Jochmans I; Monbaliu D; Pirenne J; Vanuytsel T; Gillard P; Schoemans H; Cleemput JV; Kuypers D; Vos R; Nevens F; Verbeek J
    J Med Virol; 2023 Apr; 95(4):e28736. PubMed ID: 37185854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity and safety of SARS-CoV-2 vaccine with immunosuppressive agents.
    Kamei K; Ogura M; Sato M; Nishi K; Shoji K; Funaki T; Ogimi C; Ito S
    Pediatr Int; 2022 Jan; 64(1):e15331. PubMed ID: 36331234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of antibody responses after COVID-19 vaccination in liver transplant recipients and those with chronic liver diseases.
    Thuluvath PJ; Robarts P; Chauhan M
    J Hepatol; 2021 Dec; 75(6):1434-1439. PubMed ID: 34454993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporary reduction of immunosuppression enhances production of anti-S antibody against severe acute respiratory syndrome coronavirus 2 after vaccination in kidney transplant recipients.
    Miura M; Fukumoto M; Komatsu N; Shuto R; Harada H; Sasaki H
    Int J Urol; 2022 Dec; 29(12):1505-1510. PubMed ID: 36070502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Humoral response to SARS-CoV-2 adenovirus vector vaccination (ChAdOx1 nCoV-19 [AZD1222]) in heart transplant recipients aged 18 to 70 years of age.
    Tanner R; Starr N; Chan G; Dempsey E; Heffernan E; Newman E; O'Neill J; Hannan MM; Lynch B; Joyce E
    J Heart Lung Transplant; 2022 Apr; 41(4):492-500. PubMed ID: 35090809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular immunity predominates over humoral immunity after homologous and heterologous mRNA and vector-based COVID-19 vaccine regimens in solid organ transplant recipients.
    Schmidt T; Klemis V; Schub D; Schneitler S; Reichert MC; Wilkens H; Sester U; Sester M; Mihm J
    Am J Transplant; 2021 Dec; 21(12):3990-4002. PubMed ID: 34453872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity of SARS-CoV-2 Vaccine in Kidney Transplant Recipients: A Cross-Sectional Study in Korea.
    Song SH; Chung KY; Jee Y; Chung HS; Kim K; Minn D; Kim SK
    J Korean Med Sci; 2023 Feb; 38(5):e22. PubMed ID: 36747360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serologic response to a third dose of an mRNA-based SARS-CoV-2 vaccine in lung transplant recipients.
    Hoffman TW; Meek B; Rijkers GT; van Kessel DA
    Transpl Immunol; 2022 Jun; 72():101599. PubMed ID: 35390480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 anti-spike antibodies after a fourth dose of COVID-19 vaccine in adult solid-organ transplant recipients.
    Perrier Q; Lupo J; Gerster T; Augier C; Falque L; Rostaing L; Pelletier L; Bedouch P; Blanc M; Saint-Raymond C; Boignard A; Bonadona A; Noble J; Epaulard O
    Vaccine; 2022 Oct; 40(44):6404-6411. PubMed ID: 36184404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutralization of SARS-CoV-2 Variants in Transplant Recipients After Two and Three Doses of mRNA-1273 Vaccine : Secondary Analysis of a Randomized Trial.
    Kumar D; Ferreira VH; Hall VG; Hu Q; Samson R; Ku T; Ierullo M; Majchrzak-Kita B; Tomlinson G; Gingras AC; Humar A
    Ann Intern Med; 2022 Feb; 175(2):226-233. PubMed ID: 34807716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-SARS-CoV-2 spike protein and neutralizing antibodies at 1 and 3 months after three doses of SARS-CoV-2 vaccine in a large cohort of solid organ transplant patients.
    Kamar N; Abravanel F; Marion O; Esposito L; Hebral AL; Médrano C; Guitard J; Lavayssière L; Cointault O; Nogier MB; Bellière J; Faguer S; Couat C; Del Bello A; Izopet J
    Am J Transplant; 2022 May; 22(5):1467-1474. PubMed ID: 35000296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of SARS-CoV-2 Antibody Response 4 Weeks After Homologous vs Heterologous Third Vaccine Dose in Kidney Transplant Recipients: A Randomized Clinical Trial.
    Reindl-Schwaighofer R; Heinzel A; Mayrdorfer M; Jabbour R; Hofbauer TM; Merrelaar A; Eder M; Regele F; Doberer K; Spechtl P; Aschauer C; Koblischke M; Paschen C; Eskandary F; Hu K; Öhler B; Bhandal A; Kleibenböck S; Jagoditsch RI; Reiskopf B; Heger F; Bond G; Böhmig GA; Strassl R; Weseslindtner L; Indra A; Aberle JH; Binder M; Oberbauer R
    JAMA Intern Med; 2022 Feb; 182(2):165-171. PubMed ID: 34928302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Higher Proinflammatory Cytokines Are Associated With Increased Antibody Titer After a Third Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients.
    Karaba AH; Zhu X; Benner SE; Akinde O; Eby Y; Wang KH; Saraf S; Garonzik-Wang JM; Klein SL; Bailey JR; Cox AL; Blankson JN; Durand CM; Segev DL; Werbel WA; Tobian AAR
    Transplantation; 2022 Apr; 106(4):835-841. PubMed ID: 35085183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.